antheia.bioHealthcareFounded: 2013Funding to Date: $136.64MM
Antheia is the developer of a novel whole-cell engineering approach to reconstruct complex molecules in yeast and a platform designed to enables the discovery and manufacturing of plant-inspired drugs of unprecedented complexity and diversity.
